Heraudet L, Galtier J, Favre S, Peyraud F, et al. VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapse. Br J Haematol 2022;198:523-527.
PMID: 35524489